The use of intravenous thrombolytics in acute ischemic stroke management: A scoping review from 2008 till 2021 in the Arab world in the Middle East and North Africa

• Published in: Journal of stroke and cerebrovascular diseases 2023-08, Vol.32 (8), p.107201-107201, Article 107201
• Main Authors: Malaeb, Diana, Hallit, Souheil, Sakr, Fouad, Dabbous, Mariam, Saadeh, Wadih, Mansour, Sara, Cherri, Sarah, Sarayeldyine, Sara Abir, Salameh, Pascale, Hosseini, Hassan
• Format: Article
• Language: English
• Subjects: Acute treatment; Africa, Northern; Arab World; Fibrinolytic Agents - adverse effects; Humans; Intravenous thrombolysis; Ischemic Stroke; Middle East - epidemiology; Scoping review; Stroke - diagnosis; Stroke - drug therapy
• ISSN: 1052-3057; 1532-8511
• DOI: 10.1016/j.jstrokecerebrovasdis.2023.107201

The aim of this review was to assess and analyze the research output on intravenous thrombolysis in acute ischemic stroke in the Arab world in the Middle East and North Africa. Published literature on intravenous thrombolysis for acute ischemic stroke from 2008 to 2021 were retrieved from several electronic databases. Extracted records were analyzed in terms of year of publication, country, journal, research area, authors, and organizational affiliations. A total of 37 studies were published between 2008 and 2021 from different Arab countries. Eight studies assessed the safety and efficacy of thrombolytic agents in AIS. Three studies were KAP studies addressing the knowledge, attitude and practice towards IVT. The majority of the selected studies (n=16) discussed the utilization rate of IVT among patients in different hospital settings across these countries. Ten studies reported the outcomes associated with the use of IVT for AIS. This is the first scoping review to study the research activity related to the use of IVT in stroke in the Arab nations. In the last 15 years, stroke research productivity was very low in the Arab world compared to other regions of the world due to several impeding factors. Given the high burden of in-adherence to acute stroke treatment in the Arab nations, there is a serious need for an increased high-quality research activity to highlight the roadblocks associated with the limited use of IVT.